Submit your research today!
Expert Opinion on Investigational Drugs- Developments of investigational treatments for genitourinary tumors
About the special issue
Genitourinary tumors encompass a broad range of cancer types within the urinary system and male reproductive system and there are a plethora of novel investigational drugs under current clinical development for future treatments. Candidate drugs can range from Von Hippel–Lindau inhibitors, antibody-drug conjugates, anti-angiogenesis tyrosine kinase inhibitors, immune checkpoint inhibitors, and mTOR inhibitors, with each presenting important differences and considerations for individual tumors and when used in combination therapies.
In this special issue Expert Opinion on Investigational Drugs has teamed up with key opinion leaders in the field:
• Dr Alessandro Rizzo – IRCCS Istituto Tumori Giovanni Paolo II-Bari, SSD Oncologia ‘Don Tonino Bello’, Italy
• Dr Francesco Massari – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
• Dr Veronica Mollica – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
This issue aims to cover recent progress of investigational drugs and the implications on the future clinical development across all types of genitourinary cancers, in urinary systems of both men and women and the reproductive organs in men, including but not limited to:
• Adrenal cancers
• Bladder cancers
• Kidney cancers
• Penile cancers
• Prostate cancers
• Testicular cancers
The issue welcomes authors to submit relevant interviews, editorials, reviews, drug evaluations, meta-analyses, systematic reviews, and original research. If you are interested in contributing or would like to learn more, then please reach out to the Commissioning Editor, Ryan Gilroy , who will be happy to assist.
Submission information
Submission Deadlines:
Standard track: 12th February 2024
Rapid track: 4th March 2024
Fast track: 1st April 2024
Accelerated Publication
Publish in 3 – 5 weeks from submission
Submission to acceptance: 2 – 3 weeks
1 – 2 weeks for peer review
1 week for author revision
Acceptance to online publication: 1 – 2 weeks, with proofs within 5 working days and 48 hours for author review
Cost per article: $7000 / €6200 / £5500
Publish in 7 – 9 weeks from submission
Submission to acceptance: 5 – 6 weeks
3 – 4 weeks for peer review
2 weeks for author revision
Acceptance to online publication: 2 – 3 weeks, with proofs within 10 working days
Cost per article: $3900 / €3400 / £3000
By publishing in Expert Opinion on Investigational Drugs you will:
Gain recognition from an international audience and increase your opportunities for future collaboration
Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site
Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
Increase the discoverability of your research with MEDLINE listings and more
When you are ready to submit your article, communicate the significance of your original research in a clear language to a broad audience using Plain Language Summary.
Open access makes published academic research freely and permanently available so anyone, anywhere can read and build upon this research. We champion researcher choice with a variety of open access publishing options to meet the unique needs of each author.
Considering publishing multimedia content? Research shows an increase in engagement and visibility when your research is accompanied by multimedia. Get in touch with Senior Editor Priti Nagda to discuss any specific requests.
Want to keep competitive advantage by getting your discoveries to market quickly? Or is time critical in your publishing strategy? Discover our Accelerated Publication options to help get your research into a high-quality, peer-reviewed journal, fast.
Explore the 2023 Expert Collection Calendar of special themed issues. Each special themed issue will be a one-stop resource for those interested in the field. By publishing your article, you can reap the benefits of the collection’s visibility and high impact.
Conference material supplements can include the following article types: Poster extracts, Conference abstracts, and Presentation extracts. Open access conference material supplements are peer-reviewed, permanent, and citable.
Pre-submission manuscript preparation can help you maximize the impact of your research and improve the quality of your manuscript. Services include English Language Editing, Scientific Editing, Manuscript formatting, and many more!